Create Account | Sign In: Author or Forum

News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
Category: Rheumatology | Monthly Briefing

Back to Journal Articles

October 2010 Briefing - Rheumatology

Last Updated: November 01, 2010.


Share |

Comments: (0)




Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

FDA: Methotrexate Injection Vials Recalled

FRIDAY, Oct. 29 (HealthDay News) -- The U.S. Food and Drug Administration and Sandoz have notified health care professionals of a voluntary recall of 24 lots of methotrexate injection (50 mg/2 mL and 250 mg/10 mL vials) due to the presence of small glass particulates in a limited number of vials in four lots.

More Information

Primary Care Trails Other Specialties in Hourly Wages

TUESDAY, Oct. 26 (HealthDay News) -- Primary care physicians have substantially lower hourly wages than other specialists, and although most physicians find Medicare reimbursement inequitable, they show little consensus on how to reform it, according to two studies published in the Oct. 25 issue of the Archives of Internal Medicine.

Abstract - Leigh
Full Text (subscription or payment may be required)
Abstract - Federman
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Cortisone May Help Tennis Elbow in Short Term

FRIDAY, Oct. 22 (HealthDay News) -- Cortisone injections may provide better short-term relief from tennis elbow than other treatments, but the results don't last beyond three to six weeks, according to research published online Oct. 22 in The Lancet.

Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Risk of Restless Legs Found Higher in Fibromyalgia Patients

WEDNESDAY, Oct. 20 (HealthDay News) -- Individuals with fibromyalgia appear to have a substantially higher risk of restless legs syndrome (RLS), according to research published in the Oct. 15 issue of the Journal of Clinical Sleep Medicine.

Full Text (subscription or payment may be required)

Spinal Fractures Spotlighted During World Osteoporosis Day

WEDNESDAY, Oct. 20 (HealthDay News) -- Spinal fractures worldwide occur at an estimated rate of one every 22 seconds, and health care professionals need to be able to recognize the signs of these fractures in their patients, according to the International Osteoporosis Foundation (IOF) report, The Breaking Spine.

Full Text

Expectations Don't Predict Recovery Time for All Injuries

FRIDAY, Oct. 15 (HealthDay News) -- Recovery expectations appear to predict future recovery among workers filing injury claims for back pain but not for those filing claims for other musculoskeletal conditions, according to a study published in the October issue of the Journal of Spinal Disorders & Techniques.

Full Text (subscription or payment may be required)

Fibromyalgia Sufferers May Benefit From Yoga Practice

THURSDAY, Oct. 14 (HealthDay News) -- Yoga might provide an effective counterpart to pharmacotherapy in helping patients cope with and manage fibromyalgia, according to research published in the November issue of Pain.

Full Text (subscription or payment may be required)

Older Women at Fracture Risk in Spinal Instrumentation Surgery

TUESDAY, Oct. 12 (HealthDay News) -- Postmenopausal women who have spinal fusion with instrumentation are at risk of developing fractures at other nearby vertebrae, usually within two years of the surgery, according to a study in the Oct. 1 issue of Spine.

Full Text (subscription or payment may be required)

Arthritis Prevalence Nearly 25 Percent in U.S. Adults

FRIDAY, Oct. 8 (HealthDay News) -- Nearly a quarter of U.S. adults have doctor-diagnosed arthritis and many also have arthritis-attributable activity limitation (AAAL); the prevalence of arthritis is particularly high among obese individuals, according to a report published in the Oct. 8 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text

Abatacept Found Ineffective for Non-Life-Threatening Lupus

THURSDAY, Oct. 7 (HealthDay News) -- In patients with non-life-threatening systemic lupus erythematosus (SLE), abatacept fails to prevent new flares and has a nearly one-in-five rate of serious adverse events (SAEs), according to a study in the October issue of Arthritis & Rheumatism.

Full Text (subscription or payment may be required)

DMARDs, Glucocorticoids, Biologics Similar for RA

FRIDAY, Oct. 1 (HealthDay News) -- Treatment of rheumatoid arthritis (RA) with disease-modifying antirheumatic drugs (DMARDs), glucocorticoids, biologics, or a combination of these agents significantly reduces radiographic evidence of joint destruction, with no advantage seen for patients whose treatment includes biologics, according to research published in the October issue of Arthritis & Rheumatism.

Full Text (subscription or payment may be required)

FDA Calls for Halt on Marketing of Unapproved Colchicine

FRIDAY, Oct. 1 (HealthDay News) -- The U.S. Food and Drug Administration has ordered companies manufacturing, distributing, or marketing unapproved single-ingredient oral colchicine to cease doing so.

More Information

Copyright © 2010 ScoutNews, LLC. All rights reserved.

Previous: October 2010 Briefing - Pulmonology Next: October 2010 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.

Submit your opinion:





Remember my personal information

Notify me of follow-up comments?


Useful Sites
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2016
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.